World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
22011
World Ranking
2556
National Ranking
8

Lisa F. P. Ng publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lisa F. P. Ng sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 225 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lisa F. P. Ng D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lisa F. P. Ng sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lisa F. P. Ng is affiliated with the Agency for Science, Technology and Research in Singapore. Their research is primarily situated within the field of medicine, with a focus on infectious diseases, immunology, public health, environmental and occupational health, neurology, and epidemiology.

Their work extensively covers several main topics including SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, the long-term effects of COVID-19, mosquito-borne diseases and control, SARS-CoV-2 detection and testing, animal virus infections studies, and viral infections and vectors.

Frequent publication venues for their research include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Frontiers in Immunology
  • Clinical & Translational Immunology
  • Nature Communications

They have collaborated regularly with several co-authors, including:

  • Laurent Rénia (115 publications)
  • David Chien Lye (72 publications)
  • Barnaby Edward Young (69 publications)
  • Siew-Wai Fong (64 publications)
  • Yee-Sin Leo (50 publications)

Their recent papers include:

  • "The trinity of COVID-19: immunity, inflammation and intervention," 2020, Nature Reviews Immunology
  • "Immunity, endothelial injury and complement-induced coagulopathy in COVID-19," 2020, Nature Reviews Nephrology
  • "Advances in targeted therapy for esophageal cancer," 2020, Signal Transduction and Targeted Therapy
  • "Monkeypox: disease epidemiology, host immunity and clinical interventions," 2022, Nature Reviews Immunology
  • "Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study," 2020, The Lancet

Best Publications

  • The trinity of COVID-19: immunity, inflammation and intervention.

    Matthew Zirui Tay;Chek Meng Poh;Laurent Rénia;Laurent Rénia;Paul A MacAry

  • Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

    Yijun Ruan;Chia Lin Wei;Ai Ee Ling;Vinsensius B Vega

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.

    Luca Perico;Ariela Benigni;Federica Casiraghi;Lisa F.P. Ng;Lisa F.P. Ng

  • Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen

    Felicity J Burt;Weiqiang Chen;Jonathan J Miner;Deborah J Lenschow

  • Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.

    Chek Meng Poh;Guillaume Carissimo;Bei Wang;Siti Naqiah Amrun

  • Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.

    Barnaby E Young;Barnaby E Young;Siew-Wai Fong;Siew-Wai Fong;Yi-Hao Chan;Tze-Minn Mak

  • Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor

    Angela Chow;Zhisheng Her;Zhisheng Her;Edward K S Ong;Jin-miao Chen

  • Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.

    Wan Ni Chia;Feng Zhu;Sean Wei Xiang Ong;Barnaby Edward Young;Barnaby Edward Young

  • IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity

    Lisa F. P. Ng;Angela Chow;Yong-Jiang Sun;Dyan J. C. Kwek

  • Active Infection of Human Blood Monocytes by Chikungunya Virus Triggers an Innate Immune Response

    Zhisheng Her;Benoit Malleret;Monica Chan;Edward K. S. Ong

  • Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.

    Cheryl Yi Pin Lee;Raymond T.P. Lin;Laurent Renia;Laurent Renia;Lisa F.P. Ng;Lisa F.P. Ng;Lisa F.P. Ng

  • Catching bird flu in a droplet.

    Juergen Pipper;Masafumi Inoue;Lisa F.-P. Ng;Pavel Neuzil

  • A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice

    Teck-Hui Teo;Teck-Hui Teo;Fok-Moon Lum;Fok-Moon Lum;Carla Claser;Valeria Lulla

  • Chikungunya fever

    Unknown

  • Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein

    Yiu‐Wing Kam;Fok‐Moon Lum;Fok‐Moon Lum;Teck‐Hui Teo;Wendy W. L. Lee

  • A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.

    Jean-Laurent Casanova;Helen C. Su;Covid Human Genetic Effort

  • Viperin restricts chikungunya virus replication and pathology

    Terk-Shin Teng;Suan Sin Foo;Diane Simamarta;Fok-Moon Lum

  • Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.

    Barnaby E Young;Barnaby E Young;Sean W X Ong;Lisa F P Ng;Danielle E Anderson

  • Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection

    Yiu-Wing Kam;Diane Simarmata;Angela Chow;Zhisheng Her;Zhisheng Her

  • Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro

    Yiu-Wing Kam;Yuushi Okumura;Hiroshi Kido;Lisa F. P. Ng;Lisa F. P. Ng

Frequent Co-Authors

Laurent Rénia
Laurent Rénia Nanyang Technological University
Yee Sin Leo
Yee Sin Leo Nanyang Technological University
Barnaby Young
Barnaby Young National Centre for Infectious Diseases
David C. Lye
David C. Lye Tan Tock Seng Hospital
Julian A. Hiscox
Julian A. Hiscox University of Liverpool
Raymond T. P. Lin
Raymond T. P. Lin National University of Singapore
Paul A. Tambyah
Paul A. Tambyah National University of Singapore
Andres Merits
Andres Merits University of Tartu
Olaf Rötzschke
Olaf Rötzschke Agency for Science, Technology and Research
Marc Lecuit
Marc Lecuit Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA opens doors to various related healthcare careers. Many students interested in immunology often consider accelerated nursing pathways to quickly enter patient-focused roles. Programs such as accelerated nurse practitioner programs provide a faster route to advanced clinical positions, blending immunology knowledge with direct patient care.

For those new to healthcare, there are specialized options like the 12-month accelerated nursing programs online for non nurses which allow non-nursing graduates to swiftly transition into nursing roles. These programs emphasize foundational nursing skills alongside biological sciences, including immunology concepts.

Entry into nursing can also be made simpler through the easiest accelerated nursing programs, designed to accommodate a wide range of applicants while maintaining quality education. Similarly, which lpn programs are easiest to get into can be excellent starting points for those seeking licensed practical nurse qualifications with a shorter commitment, often incorporating immunology fundamentals relevant to patient care.

Understanding these options can help immunology students align their educational choices with career goals that emphasize applied healthcare and clinical expertise.

Best Scientists Citing Lisa F. P. Ng

Trending Scientists

Recently Published Articles